Skip to content

The effect of zataria multiflora boiss on symptoms of asthmatic patients

The preventive effect of aqueous – alcoholic extract of Zataria multiflora and carvacrol on asthma disease

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
IRCT
Registry ID
IRCT2014101519546N1
Enrollment
Unknown
Registered
2016-11-26
Start date
2015-07-23
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Asthma. Mixed asthma

Interventions

Intervention 1: Control group: placebo (5 ml syrup orally three times daily). Intervention 2: Intervention group 1: Zataria multiflora Boiss syrup (5 mg milligrams per kilogram daily). Intervention 3
Treatment - Drugs
Control group: placebo (5 ml syrup orally three times daily)
Intervention group 1: Zataria multiflora Boiss syrup (5 mg milligrams per kilogram daily)
Intervention group 2: Zataria multiflora Boiss syrup (10 milligrams per kilogram daily)
Intervention group 3: Capsule of active ingredient (carvacrol 1.2 milligrams per kilogram daily)

Sponsors

Vice chancellor for research, Mashhad University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 60 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: diagnosis of asthma, according to World Health Organization criteria, guidelines on diagnosis and management of asthma (GINA), patient willingness to participate in the project. exclusion criteria: the existence of systemic diseases, Taking other medicines with antioxidant properties, taking any herbal thyme intolerance side effects (nausea, vomiting, diarrhea, etc.), inflammatory disease, gestational, age below 12 years

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Volume and lung capacity. Timepoint: Baseline, the end of First and second month. Method of measurement: Spirometry.;Serum cytokines. Timepoint: zero and sixty days. Method of measurement: ELAISA.;Cells blood. Timepoint: zero, thirty and sixty days. Method of measurement: Auto analyzer.;Gen expression. Timepoint: zero and sixty days. Method of measurement: Real time PCR.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMohammad hossein Boskabady

Mashhad University of Medical Sciences

boskabadymh@mums.ac.ir+98 51 3800 2228

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026